Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cyclerion Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CYCN
Nasdaq
8731
https://www.cyclerion.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cyclerion Therapeutics Inc
12 Best Biotech Penny Stocks to Invest In
- Mar 24th, 2024 7:54 pm
Cyclerion Appoints Regina Graul, Ph.D., as President
- Dec 4th, 2023 1:00 pm
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
- Nov 30th, 2023 11:16 pm
Cyclerion Therapeutics' Market Cap Drops To US$5.0m Leaving Insiders With Losses
- Nov 28th, 2023 2:23 pm
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
- Jul 31st, 2023 11:00 am
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Jun 1st, 2023 8:00 pm
Cyclerion Announces Reverse Stock Split
- May 15th, 2023 5:00 pm
Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors
- May 12th, 2023 6:59 pm
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
- May 11th, 2023 10:00 pm
Cyclerion Announces Corporate Updates and Q1 2023 Financial Results
- May 11th, 2023 10:00 pm
Scroll